www.cbsnews.com

www.cbsnews.com
Share

www.cbsnews.com

 •  February 12

A Japanese drug company is offering up a big claim: Shionogi & Co. says it has an experimental pill that can kill the flu virus within a single day, according to news reports. In a clinical trial, a single dose of the drug made by the pharmaceutical company eliminated the virus from people's bodies in a median time of 24 hours, The Wall Street...

www.cbsnews.com

 •  February 12

President Donald Trump makes big promises to reduce prescription drug costs, but his administration is gravitating to relatively modest steps such as letting Medicare patients share in manufacturer rebates. Those ideas would represent tangible change and they have a realistic chance of being enacted. But it's not like calling for Medicare to...

www.cbsnews.com

 •  February 7

WASHINGTON — U.S. health authorities say the herbal supplement kratom, which is often promoted as a natural alternative pain remedy, actually contains the same chemicals found in opioids, the addictive family of drugs at the center of a national addiction crisis. The Food and Drug Administration analysis, published Tuesday, makes it more likely...

www.cbsnews.com

 •  January 25

SACRAMENTO -- Dan Diaz told lawmakers it never gets easier to talk about. But three years since his wife Brittany Maynard moved to Oregon to end her suffering from terminal brain cancer, his fight in California isn't quite done. Diaz returned to the Capitol, with pictures of Brittany on the day they got married. He says it's to remind people of the...

www.cbsnews.com

 •  January 12

U.S. regulators have approved the first drug aimed at women with advanced breast cancer caused by an inherited flawed gene. The Food and Drug Administration on Friday approved AstraZeneca PLC's Lynparza for patients with inherited BRCA gene mutations who have undergone chemotherapy. The drug has been on the market since 2014 for ovarian cancer, and...

www.cbsnews.com

 •  December 26, 2017

Prices for a cancer drug called lomustine have skyrocketed nearly 1,400 percent since 2013, putting a potentially life-saving treatment out of reach for patients suffering from brain tumors and Hodgkin's lymphoma. Though the 40-year-old medication is no longer protected by patents, no generic version is available. According to the Wall Street...

www.cbsnews.com

 •  December 11, 2017

SACRAMENTO, Calif. - Pharmaceutical companies on Friday sued to block a new California law that would require them to give advance notice before big price increases. The law was approved this year in response to consumer outrage over a rise in drug spending and high costs for some prescription treatments, including new hepatitis C medications and...

www.cbsnews.com

 •  December 6, 2017

TRENTON, N.J. — U.S. regulators on Tuesday approved a new diabetes drug that reduces blood sugar levels and also helps people lose significant weight. Danish drugmaker Novo Nordisk said the Food and Drug Administration approved its once-a-week shot for people with Type 2 diabetes. The drug, Ozempic, also known as semaglutide, works by stimulating...

www.cbsnews.com

 •  November 14, 2017

WASHINGTON -- The Food and Drug Administration has approved the first drug in the United States with a digital ingestion tracking system, in an unprecedented move to ensure that patients with mental illness take the medicine prescribed for them. The drug Abilify MyCite was developed by Otsuka Pharmaceutical Co., Ltd. The drug Abilify was first...

www.cbsnews.com

 •  November 11, 2017

Actor Chuck Norris and his wife, Gena, are suing 11 medical companies after they say she was poisoned by a drug used during a routine MRI scan. The drug is a contrast agent, which enhances MRI images and helps with diagnosis. The companies that make contrast agents say they are safe and have been used to aid in the treatment of millions of...